SuperNova Diagnostics has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology (KSB), a biotechnology diagnostics company manufacturing and distributing in-vitro diagnostic kits and research reagents in China and affiliated markets.
With the agreement, SuperNova will expand into China with in vitro diagnostic kit maker KSB.
SuperNova Diagnostics president and CEO Neil Campbell said this collaborative relationship allows SuperNova and KSB to expand R&D, manufacturing, and commercialization into one of the world’s largest markets.
SuperNova Diagnostics’ AmpCrystal technology with multiple product formats allows for minimally trained individuals (advanced CLIA-waived) to test for a wide range of protein analytes and can detect directly un-amplified DNA in humans, animals or environmental samples.
AmpCrystal is hyper-dense, energy-mediated proprietary nanocrystals that can be utilized in a wide variety of diagnostic applications and configurations.